Corvò R, Margarino G, Sanguineti G, Geido E, Scala M, Mereu P, Cavallari M, Bonanno S, Garaventa G, Barbieri M, Giaretti W
Reparto di Oncologia Radioterapica, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Tumori. 2000 Jan-Feb;86(1):53-8. doi: 10.1177/030089160008600110.
The increasing complexity of management strategies for patients with head and neck squamous cell carcinoma (HN-SCC) calls for the investigation of new objective prognostic parameters to subdivide patients according to the tumor's biological aggressiveness.
We evaluated in 35 HN-SCC patients the pretreatment cell kinetics parameters and DNA ploidy after in vivo infusion of bromodeoxyuridine and flow cytometric analysis. Patients were treated with radical surgery followed by conventional radiation therapy. Locoregional control data are available for follow-up times above five years.
We found that the likelihood of locoregional control for patients with rapidly proliferating HN-SCC characterized by a short potential doubling time (Tpot <5 days) was significantly smaller than for HN-SCC patients with slow tumor proliferation (Tpot >5 days). Moreover, when patients were stratified according to DNA ploidy and Tpot value, we found that the locoregional failure rate for rapidly proliferating tumors was significantly higher for diploid HN-SCCs than for aneuploid HN-SCCs.
The present data suggest that patients with resectable HN-SCC characterized by fast growth might have a worse prognosis after surgery and adjuvant conventional radiotherapy and might benefit from more aggressive radiotherapeutic modalities.
头颈部鳞状细胞癌(HN-SCC)患者管理策略的复杂性日益增加,这就需要研究新的客观预后参数,以便根据肿瘤的生物学侵袭性对患者进行细分。
我们对35例HN-SCC患者在体内注入溴脱氧尿苷并进行流式细胞术分析后,评估其治疗前的细胞动力学参数和DNA倍性。患者接受根治性手术后进行传统放疗。局部区域控制数据可用于随访时间超过五年的情况。
我们发现,以短潜在倍增时间(Tpot<5天)为特征的快速增殖型HN-SCC患者的局部区域控制可能性显著低于肿瘤增殖缓慢(Tpot>5天)的HN-SCC患者。此外,当根据DNA倍性和Tpot值对患者进行分层时,我们发现二倍体HN-SCC中快速增殖肿瘤的局部区域失败率显著高于非整倍体HN-SCC。
目前的数据表明,以快速生长为特征的可切除HN-SCC患者在手术和辅助传统放疗后的预后可能较差,可能从更积极的放疗方式中获益。